Navigation Links
Synthetic biology: Is ethics a showstopper?
Date:12/3/2008

WASHINGTON Synthetic biology promises to enable cheap, lifesaving new drugs to treat the 350-500 million people who suffer from malaria, and to create innovative biofuels that can help solve the world's energy problems. But the science and its applications are raising questions: Are synthetic biologists playing God? Are these scientists purposely changing the definition of what is life? Are synthetic biology researchers unintentionally equipping terrorists with frightening new biological weapons? And will synthetic biology's expected products and profits be stymied by policymakers and the public who object to researchers' soon-to-be-realized attempts to build life from scratch in a lab?

Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania, will explore unresolved synthetic biology ethical questions at a January 8 program with Project on Emerging Nanotechnologies Chief Science Advisor Andrew Maynard. Dr. Caplan is at the forefront of ethicists, theologians, scientists, engineers, government leaders and civil society groups working to weigh synthetic biology's potential risks and benefits.

Caplan is the author or editor of 25 books and over 500 articles in professional medical, science and bioethics journals. He has served on a number of national and international committees including as chair of the National Cancer Institute Biobanking Ethics Group, and chair of the Advisory Committee to the United Nations on Human Cloning. His most recent book is Smart Mice, Not So Smart People (Rowman Littlefield, 2006).

The Rathenau Instituut, a unit of the Royal Netherlands Academy of Arts and Sciences (KNAW), describes synthetic biology as the convergence of molecular biology, information technology and nanotechnology, leading to the systematic design of biological systems. The U.S. is considered the world leader in this emerging field of science. Some estimate that by 2015, a fifth of the chemical industry (worth $1.8 trillion) could be dependent on synthetic biology.

To attend this event, RSVP to nano@wilsoncenter.org. No RSVP is required to view the Web cast.

*** Web cast LIVE at www.wilsoncenter.org ***

What: Synthetic Biology: Is Ethics a Showstopper?

When: Thursday, January 8, 2009, 12:30 1:30 PM (Light lunch available at 12 noon.)

Who: Arthur Caplan, Ph.D., Chair, Department of Medical Ethics and Director, Center for Bioethics, University of Pennsylvania
Andrew Maynard, Ph.D., Chief Science Advisor, Project on Emerging Nanotechnologies, Moderator

Where: Woodrow Wilson International Center for Scholars, 5th Floor Conference Room in the Ronald Reagan Building at 1300 Pennsylvania Avenue, NW, Washington, DC. For directions see: http://www.wilsoncenter.org/directions


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology news :

1. Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues
2. Synthetic compound promotes death of lung-cancer cells, tumors
3. Experts from Stevens, Merck, publish joint paper, Biosynthetic Studies of Platensimycin
4. Researchers decode genetics of rare photosynthetic bacteria
5. Researchers decode genetics of rare photosynthetic bacterium
6. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
7. Berkeley researchers identify photosynthetic dimmer switch
8. Oregano oil works as well as synthetic insecticides to tackle common beetle pest
9. New projects to raise UK profile in synthetic biology
10. Synthetic Biology: funders move to address social and ethical challenges
11. Synthetic cocoa chemical slows growth of tumors in human cell lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... just published their findings on what they believe could be a new and ... of the new research. Click here to read it now. , ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
Breaking Biology Technology: